Neyssa Marina

Professor of Pediatrics (Hematology/Oncology) at the Lucile Salter Packard Children's Hospital

Sarcoma Program

Professional Education

  • Board Certification: Pediatrics, American Board of Pediatrics (1987)
  • MS, Stanford University, Epidemiology (2011)
  • Fellowship: St Jude Children's Research Hospital (1989) TN
  • Internship: University Pediatric Hospital (1984) Puerto Rico
  • Residency: University Pediatric Hospital (1986) Puerto Rico
  • Board Certification: Pediatric Hematology-Oncology, American Board of Pediatrics (1990)
  • Medical Education: University of Puerto Rico (1983) Puerto Rico
  • BS, University of PR, Mayaguez, Chemistry (1979)
  • MD, University of PR, Medicine (1983)
  • Residency, University of PR, Pediatrics (1986)
  • Fellowship, St. Jude Children's Hospital, Pediatric Hematology-Oncology (1989)

Honors & Awards

  • Magna Cum Laude-Antoine Lavoiser Chemistry Award, University of PR, Mayaguez Campus (1979)
  • Phi Kappa Phi Honor Society, Phi Kappa Phi (1979)
  • Alfa Omega Alfa Honor Society, Alfa Omega Alfa (1982)

Administrative Appointments

  • Director of Hematology-Oncology Outpatient Clinic, Lucile Packard Children's Hospital (2000 - Present)
  • Director, Pediatric Hematology-Oncology Fellowship Program, Stanford University (2000 - 2008)
  • Associate Chief of Clinical Affairs, Pediatric Hematology-Oncology, Lucile Packard Children's Hospital (2006 - 2011)
  • Oncology Section Chief, Stanford University, Division of Pediatric Hematology-Oncology (2013 - Present)

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.